HomeLatest NewsFederal NewsFDA Identifies Philips Respironics Recall as Class 1

FDA Identifies Philips Respironics Recall as Class 1

Philips Respironics has recalled certain V60 and V60 Plus ventilators because some of them could stop working due to an expired adhesive, the Food and Drug Administration announced this week. FDA has identified this as a Class 1 recall, the most serious type because it may cause serious injury or death. No injuries or adverse health consequences have been reported.

The Philips Respironics V60 and V60 Plus ventilators are intended to support patient breathing. They are used to provide mechanical ventilation for adults and children who can breathe on their own, for example those with respiratory failure, chronic respiratory insufficiency, or obstructive sleep apnea. The ventilators are used in hospitals or other institutional settings under the direction of health care professionals.

Who May be Affected

  • People receiving care with the Philips Respironics V60 or V60 Plus ventilators.
  • Health care personnel who provide care for patients using Philips Respironics V60 or V60 Plus ventilators.

Customers with questions or concerns about this recall should contact Philips Respironics 24/7 – Customer Care Solutions Center at 1-800-722-9377.

Stay Connected

Unified Voice Newsletter

Events This Month

Current Month

November

21nov8:00 am9:00 amConcurrent Care: Reimbursement for Providing Care for ChildrenWebinar

21nov12:00 pm1:00 pmThe Role of Hospitals in Optimizing Postpartum Mental Health SupportAHA Webinar

21nov12:00 pm1:30 pmPediatric Chaplaincy & Spiritual Care: An Introduction, Best Practices, and State of the ResearchNACC webinar

21nov1:00 pm2:00 pmLaunching into PDPM Success: Boost Your Facility's Performance & Compliance with these PDPM-Based StrategiesSDAHO Webinar